Axogen (AXGN) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.56% |
| Dec 31, 2025 | -12.70% |
| Sep 30, 2025 | 30.81% |
| Jun 30, 2025 | 17.11% |
| Mar 31, 2025 | 27.87% |
| Dec 31, 2024 | 17.84% |
| Sep 30, 2024 | 44.70% |
| Jun 30, 2024 | 43.86% |
| Mar 31, 2024 | 14.88% |
| Dec 31, 2023 | 11.41% |
| Sep 30, 2023 | 3.60% |
| Jun 30, 2023 | -7.45% |
| Mar 31, 2023 | -8.02% |
| Dec 31, 2022 | -25.43% |
| Sep 30, 2022 | -26.51% |
| Jun 30, 2022 | -40.53% |
| Mar 31, 2022 | -28.75% |
| Dec 31, 2021 | -14.50% |
| Sep 30, 2021 | -41.44% |
| Jun 30, 2021 | -34.82% |
| Mar 31, 2021 | -18.85% |
| Dec 31, 2020 | -15.17% |
| Sep 30, 2020 | 11.44% |
| Jun 30, 2020 | -30.83% |
| Mar 31, 2020 | -27.32% |
| Dec 31, 2019 | -22.32% |
| Sep 30, 2019 | -27.66% |
| Jun 30, 2019 | -27.27% |
| Mar 31, 2019 | -27.81% |
| Dec 31, 2018 | -15.92% |
| Sep 30, 2018 | -16.25% |
| Jun 30, 2018 | -17.03% |
| Mar 31, 2018 | -16.52% |
| Dec 31, 2017 | 4.13% |
| Sep 30, 2017 | 6.01% |
| Jun 30, 2017 | 1.85% |
| Mar 31, 2017 | -10.52% |
| Dec 31, 2016 | -6.46% |
| Sep 30, 2016 | 14.76% |
| Jun 30, 2016 | -2.05% |
| Mar 31, 2016 | -23.80% |
| Dec 31, 2015 | -12.86% |
| Sep 30, 2015 | -16.89% |
| Jun 30, 2015 | -44.77% |